Deep Brain Stimulation Devices Market Size, Trends & Forecast 2035
According to Payal Rabde, who specializes in the management of Parkinson’s disease, essential tremor, dystonia, and epilepsy, advanced implantable pulse generators, and AI-enabled programming and remote device monitoring, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the deep brain stimulation devices market. The global deep brain stimulation devices market size was estimated at USD 2.15 billion in 2025 and is predicted to increase from USD 2.34 billion in 2026 to approximately USD 5.04 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035. Her analysis highlights the increasing adoption of implantable deep brain stimulation systems, rechargeable and adaptive neurostimulators, MRI-compatible DBS devices, remote patient monitoring and wireless device management, and advanced neuroimaging and surgical navigation technologies. The research also examines the competitive strategies of key industry participants, including, Medtronic, Abbott, Boston Scientific, Aleva Neurotherapeutics, Newronika, NeuroPace, Rune Labs, and Cala Health, shaping the future by advancing closed-loop deep brain stimulation system, integrating artificial intelligence, expanding minimally invasive neurosurgical techniques, developing MRI-compatible and directional lead technologies, and accelerating innovation in neuromodulation technologies in the global deep brain stimulation devices market.
Last Updated : 20 July 2026
Category: Medical Devices
Insight Code: 6835
Format: PDF / PPT / Excel